![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » MANUFACTURING DOUBLE WHAMMY TO COST PATHEON MILLIONS
MANUFACTURING DOUBLE WHAMMY TO COST PATHEON MILLIONS
August 16, 2006
More problems at Patheon's Puerto Rican production facilities in the third quarter of 2006 are expected to reduce the contract manufacturer's earnings before interest, tax, depreciation and amortisation (EBITDA) by more than $9m (7m) compared to last year, forcing it to negotiate its credit agreement with its lenders. Outsourcing-Pharma (http://www.outsourcing-pharma.com/news/ng.asp?n=69845-patheon-puerto-rico-mova-omnicef)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct